Nasdaq confirms Celularity compliant with listing rule after late 10-Qs; deficiency closed

Celularity Inc

Nasdaq notified Celularity on Sept 2, 2025 that it has regained compliance with Listing Rule 5250(c)(1).
Compliance determination based on the Aug 29, 2025 filing of Q1 2025 10-Q and Q2 2025 10-Q.
Listing Rule 5250(c)(1) requires timely filing of periodic financial reports.
The previously reported deficiency is now closed, removing immediate delisting risk.
Celularity is now current with its SEC periodic filings through June 30, 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.